| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ISHARES TR | 13,865 | 173,118,000 | 16.96% | Put | |
| 2 | ALLERGAN PLC | 177,100 | 53,743,000 | 5.26% | ||
| 3 | SPDR S&P BIOTECH ETF | 2,000 | 50,448,000 | 4.94% | Put | |
| 4 | TEVA PHARMACEUTICAL INDUSTRIES LTD | 6,500 | 38,415,000 | 3.76% | Call | |
| 5 | GILEAD SCIENCES INC | 320,000 | 37,466,000 | 3.67% | ||
| 6 | PFIZER INC | 874,013 | 29,306,000 | 2.87% | ||
| 7 | ISHARES TR | 750 | 27,673,000 | 2.71% | Put | |
| 8 | ABBVIE INC | 407,000 | 27,346,000 | 2.68% | ||
| 9 | BIOGEN INC | 60,730 | 24,531,000 | 2.40% | ||
| 10 | MERCK & CO INC | 400,000 | 22,772,000 | 2.23% | ||
| 11 | SELECT SECTOR SPDR TR SBI HEALTHCARE | 3,000 | 22,317,000 | 2.19% | Put | |
| 12 | CELGENE CORP | 160,000 | 18,518,000 | 1.81% | ||
| 13 | PERRIGO CO PLC | 1,000 | 18,483,000 | 1.81% | Call | |
| 14 | BIOMARIN PHARMACEUTICAL INC CALL | 1,000 | 13,678,000 | 1.34% | Call | |
| 15 | MYLAN N V | 175,000 | 11,876,000 | 1.16% | ||
| 16 | ORMAT TECHNOLOGIES INC | 80,092 | 11,309,000 | 1.11% | ||
| 17 | CLOVIS ONCOLOGY INC | 120,000 | 10,546,000 | 1.03% | ||
| 18 | TEVA PHARMACEUTICAL INDS LTD | 177,300 | 10,478,000 | 1.03% | ||
| 19 | VALEANT PHARMACEUTICALS INTL | 45,750 | 10,163,000 | 1.00% | ||
| 20 | NOVARTIS A G | 100,000 | 9,834,000 | 0.96% | ||
| 21 | AMGEN INC | 60,200 | 9,242,000 | 0.91% | ||
| 22 | CONCORDIA INTERNATIONAL CORP | 100,000 | 9,025,000 | 0.88% | ||
| 23 | VERINT SYS INC COM | 139,434 | 8,470,000 | 0.83% | ||
| 24 | BIOMARIN | 60,000 | 8,207,000 | 0.80% | ||
| 25 | CHECK POINT SOFTWARE TECH LT | 91,087 | 7,246,000 | 0.71% | ||
| 26 | SHIRE PLC | 134,751 | 6,866,000 | 0.67% | ||
| 27 | SEATTLE GENETICS INC | 140,000 | 6,776,000 | 0.66% | ||
| 28 | BRISTOL MYERS SQUIBB CO | 100,000 | 6,654,000 | 0.65% | ||
| 29 | ALDER BIOPHARMACEUTICALS INC | 125,000 | 6,621,000 | 0.65% | ||
| 30 | VANDA PHARMACEUTICALS INC COM | 513,390 | 6,515,000 | 0.64% | ||
| 31 | B COMMUNICATIONS LTD | 5,977,000 | 6,448,000 | 0.63% | ||
| 32 | AMICUS THERAPEUTICS INC | 450,000 | 6,368,000 | 0.62% | ||
| 33 | AMAG PHARMACEUTICALS INC COM | 90,230 | 6,231,000 | 0.61% | ||
| 34 | PROTHENA CORP PLC | 115,133 | 6,064,000 | 0.59% | ||
| 35 | ARRAY BIOPHARMA INC COM | 800,000 | 5,768,000 | 0.56% | ||
| 36 | FORWARD PHARMA A/S | 150,000 | 5,708,000 | 0.56% | ||
| 37 | ISHARES | 192,630 | 5,371,000 | 0.53% | ||
| 38 | GW PHARMACEUTICALS PLC | 43,500 | 5,344,000 | 0.52% | ||
| 39 | CYNAPSUS THERAPEUTICS INC | 316,448 | 5,324,000 | 0.52% | ||
| 40 | INSMED INC COM PAR .01 | 215,000 | 5,250,000 | 0.51% | ||
| 41 | MEDICINES CO | 180,000 | 5,150,000 | 0.50% | ||
| 42 | TESARO INC | 87,500 | 5,144,000 | 0.50% | ||
| 43 | Catabasis Pharmaceuticals Inc | 446,036 | 5,060,000 | 0.50% | ||
| 44 | UNITED THERAPEUTICS | 28,840 | 5,017,000 | 0.49% | ||
| 45 | ACORDA THERAPEUTICS | 150,000 | 5,000,000 | 0.49% | ||
| 46 | CATALYST PHARMACEUTICALS INC | 1,200,000 | 4,956,000 | 0.49% | ||
| 47 | BELLICUM PHARMACEUTICALS INC COM | 231,514 | 4,924,000 | 0.48% | ||
| 48 | ULTRAGENYX PHARMACEUTICAL INC COM | 47,700 | 4,884,000 | 0.48% | ||
| 49 | SAREPTA THERAPEUTICS INC | 150,000 | 4,565,000 | 0.45% | ||
| 50 | DELPHI AUTOMOTIVE PLC | 53,070 | 4,516,000 | 0.44% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001178913-15-002526, filed 2015.08.06).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
